Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Jul 13, 2011
Dr. Beth Karlan gives an overview of ovarian cancer and PARP inhibitors at ASCO 2011. Beth Young Karlan, MD is Director of the Women's Cancer Research Institute, the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology and the Gilda Radner Cancer Detection Program. Dr. Karlan is also a professor of obstetrics and gynecology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA).